Terms: = Pancreatic cancer AND Cytokeratin�fragment 21-1 AND Diagnosis
44 results:
1. Long-Term Oncologic Outcome following Duodenum-Preserving pancreatic Head Resection for Benign Tumors, Cystic Neoplasms, and Neuroendocrine Tumors: Systematic Review and Meta-analysis.
Beger HG; Mayer B; Poch B
Ann Surg Oncol; 2024 Jul; 31(7):4637-4653. PubMed ID: 38578553
[TBL] [Abstract] [Full Text] [Related]
2. Cyfra 21.1: A Useful Tumour Marker in pancreatic Ductal Adenocarcinoma: Cross-Sectional Study.
Kuttanchettiyar KG; V VK; Chisthi MM
Cancer Control; 2024; 31():10732748241228037. PubMed ID: 38246662
[TBL] [Abstract] [Full Text] [Related]
3. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract] [Full Text] [Related]
4. Patient reported outcomes of duodenum-preserving pancreatic head resection in chronic pancreatitis: high effectivity is impaired by prolonged non-surgical management.
Leonhardt CS; Niesen W; Pils D; Angelova Y; Hank T; Kaiser J; Scheele C; Hinz U; Hackert T; Büchler MW; Strobel O
HPB (Oxford); 2024 Jan; 26(1):73-82. PubMed ID: 37865592
[TBL] [Abstract] [Full Text] [Related]
5. Long-Term Outcomes and Risk of pancreatic cancer in Intraductal Papillary Mucinous Neoplasms.
de la Fuente J; Chatterjee A; Lui J; Nehra AK; Bell MG; Lennon RJ; Kassmeyer BA; Graham RP; Nagayama H; Schulte PJ; Doering KA; Delgado AM; Vege SS; Chari ST; Takahashi N; Majumder S
JAMA Netw Open; 2023 Oct; 6(10):e2337799. PubMed ID: 37847503
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.
Jayakrishnan T; Nair KG; Kamath SD; Wei W; Estfan BN; Krishnamurthi SS; Khorana AA
Cancer Med; 2023 Mar; 12(6):7327-7338. PubMed ID: 36621839
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Impact of Structured Post-Operative Surveillance in Resected pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study.
Zhang D; Kruger S; Schirle K; Heinemann V; Dorman K; Westphalen CB; Weiss L; Gebauer L; Günther M; Ormanns S; Werner J; von Bergwelt-Baildon M; Boeck S; Haas M
Oncol Res Treat; 2023; 46(3):106-115. PubMed ID: 36529119
[TBL] [Abstract] [Full Text] [Related]
8. Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases.
Zhang G; Li B; Yin X; Gao S; Shen S; Wang H; Shi X; Liu W; Zheng K; Jing W; Zhang Y; He T; Li G; Hu X; Guo S; Jin G
Int J Surg; 2022 Aug; 104():106786. PubMed ID: 35868619
[TBL] [Abstract] [Full Text] [Related]
9. pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.
Cabasag CJ; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Little A; De P; Dixon E; Woods RR; Saint-Jacques N; Evans S; Engholm G; Elwood M; Merrett N; Ransom D; O'Connell DL; Bray F; Soerjomataram I
Br J Cancer; 2022 Jun; 126(12):1774-1782. PubMed ID: 35236937
[TBL] [Abstract] [Full Text] [Related]
10. Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.
Kartsonaki C; Pang Y; Millwood I; Yang L; Guo Y; Walters R; Lv J; Hill M; Yu C; Chen Y; Chen X; O'Neill E; Chen J; Travis RC; Clarke R; Li L; Chen Z; Holmes MV
Int J Epidemiol; 2022 Jun; 51(3):817-829. PubMed ID: 35064782
[TBL] [Abstract] [Full Text] [Related]
11. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lakhani NJ; Chow LQM; Gainor JF; LoRusso P; Lee KW; Chung HC; Lee J; Bang YJ; Hodi FS; Kim WS; Santana-Davila R; Fanning P; Squifflet P; Jin F; Kuo TC; Wan HI; Pons J; Randolph SS; Messersmith WA
Lancet Oncol; 2021 Dec; 22(12):1740-1751. PubMed ID: 34793719
[TBL] [Abstract] [Full Text] [Related]
12. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
13. Increased risk of cancer in patients with primary sclerosing cholangitis.
Lundberg Båve A; Bergquist A; Bottai M; Warnqvist A; von Seth E; Nordenvall C
Hepatol Int; 2021 Oct; 15(5):1174-1182. PubMed ID: 34357546
[TBL] [Abstract] [Full Text] [Related]
14. Early unplanned readmissions following same-admission cholecystectomy for acute biliary pancreatitis.
Chu BK; Gnyawali B; Cloyd JM; Hart PA; Papachristou GI; Lara LF; Groce JR; Hinton A; Conwell DL; Krishna SG
Surg Endosc; 2022 May; 36(5):3001-3010. PubMed ID: 34159465
[TBL] [Abstract] [Full Text] [Related]
15. Risk factors of pancreatic cancer in Vietnam: A Matched Case-Control Hospital-Based Study.
Van Tran T; Van Dao T; Nguyen KD; van Ta T; Vu KT; Trinh SH; Nguyen HC; Bui OT; Nguyen QT; Vu HD; Nguyen HL; Tran HT
Cancer Control; 2021; 28():1073274821989320. PubMed ID: 33517745
[TBL] [Abstract] [Full Text] [Related]
16. Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ.
Nakahodo J; Kikuyama M; Nojiri S; Chiba K; Yoshimoto K; Kamisawa T; Horiguchi SI; Honda G
Pancreatology; 2020 Dec; 20(8):1689-1697. PubMed ID: 33039293
[TBL] [Abstract] [Full Text] [Related]
17. Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer.
Paredes AZ; Hyer JM; Tsilimigras DI; Palmer E; Lustberg MB; Dillhoff ME; Cloyd JM; Tsung A; Ejaz A; Wells-Di Gregorio S; Pawlik TM
HPB (Oxford); 2021 Mar; 23(3):451-458. PubMed ID: 32843275
[TBL] [Abstract] [Full Text] [Related]
18. Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?
Merola E; Zandee W; de Mestier L; Klümpen HJ; Makulik K; Geboes K; van Velthuysen ML; Couvelard A; Cros J; van Eeden S; Hoorens A; Stephenson T; Zajęcki W; de Herder W; Munir A
Neuroendocrinology; 2021; 111(1-2):170-177. PubMed ID: 32155627
[TBL] [Abstract] [Full Text] [Related]
19. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms.
Sandini M; Strobel O; Hank T; Lewosinska M; Nießen A; Hackert T; Büchler MW; Schimmack S
Surgery; 2020 Mar; 167(3):575-580. PubMed ID: 31889543
[TBL] [Abstract] [Full Text] [Related]
20. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract] [Full Text] [Related]
[Next]
